News

FDA Press on Disclosure of Trial Data To More Than 2,200 Sponsors and Researchers

The U.S. Food and Drug Administration (FDA) recently contacted over 2,200 sponsors and researchers, urging them to submit required study data. The …

FDA Cough Drop Recall Issued Nationwide Over Safety Concerns

A recent FDA cough drop recall across the United States has been announced, after which multiple over-the-counter (OTC) throat lozenges were pulled …

Abbott Infant Formula Trial: Jury Orders The Company To $53M In Compensation

The Abbott infant formula trial has taken a major turn after a Chicago jury ordered Abbott Laboratories to pay $53 million in …

Flea-borne Typhus In LA Hits Record High: What You Need to Know Now?

Flea-borne typhus in LA has reached record levels, prompting a countywide public health alert and urging residents to take preventive measures. Los …

Launch of Higher-dose Wegovy by Novo Nordisk Fuels The Obesity Drug Race

A new, more powerful version of its popular weight-loss drug, a higher-dose Wegovy by Novo Nordisk, has been launched. Novo’s new launch …

Nasal Spray Flu Vaccine in NSW To Boost Children Immunisation

In a major public health move, New South Wales Government has introduced a free nasal flu vaccine for children aged 2 to …

FTL1 Protein Causing Brain Aging Identified In Study Conducted On Aging Mice

A groundbreaking discovery has revealed a protein causing brain aging—and scientists say reducing it may even reverse memory decline. Researchers at the …

FDA Approval For Eli Lilly’s Foundayo: A New GLP-1 Pill To Enter Obesity Drug Market

The Food and Drug Administration has approved Eli Lilly’s new medication for treating obesity. This new pill, named Foundayo, is an oral …

NHS to offer weight loss drugs to a Million Heart Patients

In a major shift in the United Kingdom public healthcare strategy, the NHS to offer weight loss drugs to more than 1.2 …

FDA Warning to Amgen's Tavneos: Fatal Liver Injuries Linked To Vasculitis Drug

The U.S. Food and Drug Administration has issued a safety alert to the biopharmaceutical company Amgen, claiming fatal liver injury cases linked …

BullFrog AI Partnership With Global Pharma Aims to Accelerate Depression Treatment Innovation

BullFrog AI Holdings, Inc. has signed a commercial agreement with a top global pharmaceutical company to accelerate drug discovery for Major Depressive …

Eli Lilly and Insilico Deal Worth $2.5B Expands AI Drug Discovery Globally

In one of the most significant pharmaceutical AI partnerships, Eli Lilly and Hong Kong-based Insilico Medicine have collaborated to develop healthcare research …